Skip to main content
. Author manuscript; available in PMC: 2011 Mar 9.
Published in final edited form as: J Clin Oncol. 2008 Jun 20;26(18):2959–2965. doi: 10.1200/JCO.2007.15.1928

Figure 1.

Figure 1

Idealized patient outcome on docetaxel (Doc) and rapid androgen cycling with leuprolide (GNRH) and testosterone repletion (T). The dotted line represents peak and trough testosterone levels in response to testosterone depletion and repletion. The solid line represents successive declines in peak and trough PSA values in response to each cycle of treatment.